Search

Your search keyword '"Hartkopf, Andreas Daniel"' showing total 34 results

Search Constraints

Start Over You searched for: Author "Hartkopf, Andreas Daniel" Remove constraint Author: "Hartkopf, Andreas Daniel"
34 results on '"Hartkopf, Andreas Daniel"'

Search Results

Catalog

Books, media, physical & digital resources

3. Endometriosis Coinciding with Uterus Didelphys and Renal Agenesis: A Literature Review.

4. Circulating Tumor DNA in Early and Metastatic Breast Cance—Current Role and What Is Coming Next.

5. Breast Cancer and Mental Health: Incidence and Influencing Factors—A Claims Data Analysis from Germany.

6. The SURVIVE study: Liquid biopsy guided surveillance after intermediate- to high-risk early breast cancer.

8. Vergleich von Trastuzumab-Biosimilar ABP 980 mit Referenz-Trastuzumab bei der neoadjuvanten Therapie von HER2-positivem Brustkrebs – Analyse eines großen universitären Brustkrebszentrums

9. Adverse Obstetric Outcomes after Breast Cancer Diagnosis: An Observational Database Study in Germany.

10. Implementation and Evaluation of a Breast Cancer Disease Model Using Real-World Claims Data in Germany from 2010 to 2020

11. Arbeitsgemeinschaft Gynäkologische Onkologie Recommendations for the Diagnosis and Treatment of Patients with Early Breast Cancer: Update 2024.

12. The Clinical Relevance of the NATALEE Study: Application of the NATALEE Criteria to a Real-World Cohort from Two Large German Breast Cancer Centers

13. Tumor-Free Resection Margin Distance in the Surgical Treatment of Node-Negative Squamous Cell Cancer of the Vulva Has No Impact on Survival: Analysis of a Large Patient Cohort in a Tertiary Care Center

14. Which Patients Do We Need to Test for BRCA1/2 Mutation? Feasibility of Adjuvant Olaparib Treatment in Early Breast Cancer–Real-World Data from Two Large German Breast Centers

16. Characteristics, Treatment Patterns and Survival of International Federation of Gynecology and Obstetrics Stage IV Epithelial Ovarian Cancer—A Population-Based Study.

17. Treatment and survival of patients with malignant ovarian sex cord‐stromal cell tumours: An analysis of the Arbeitsgemeinschaft für Gynäkologische Onkologie (AGO) study group CORSETT database

18. Comparison of Biosimilar Trastuzumab ABP 980 with Reference Trastuzumab in Neoadjuvant Therapy for HER2-positive Breast Cancer – an Analysis of a Large University Breast Cancer Centre

24. Complementary and alternative medicine and musculoskeletal pain in the first year of adjuvant aromatase inhibitor treatment in early breast cancer patients

25. ClinOmicsTrailbc: a visual analytics tool for breast cancer treatment stratification

26. The impact of HER2 phenotype of circulating tumor cells in metastatic breast cancer: a retrospective study in 107 patients

27. ClinOmicsTrailbc: a visual analytics tool for breast cancer treatment stratification.

28. CAPTOR-BC: Comprehensive analysis of spatial, temporal and molecular biomarkers predicting response and resistance to first-line treatment with ribociclib + ET in HR+, HER2- advanced breast cancer.

30. Serial enumeration of circulating tumor cells predicts treatment response and prognosis in metastatic breast cancer: a prospective study in 393 patients

31. Prevalence and prognostic value of disseminated tumor cells in primary endometrial, cervical and vulvar cancer patients

32. The presence and prognostic impact of apoptotic and nonapoptotic disseminated tumor cells in the bone marrow of primary breast cancer patients after neoadjuvant chemotherapy

33. The prognostic impact of circulating tumor cells in subtypes of metastatic breast cancer

34. The presence and prognostic impact of apoptotic and nonapoptotic disseminated tumor cells in the bone marrow of primary breast cancer patients after neoadjuvant chemotherapy